MIAMI,
Sept. 22, 2022 – PRESS RELEASE – Ayr Wellness Inc., a leading vertically integrated U.S.
multistate cannabis operator, announced the launch of Lost in Translation
(LIT), an award winning cannabis brand known for sought after genetics and
terpene profiles, across four additional states in Ayr’s operational footprint:
Arizona, Florida, New Jersey and Pennsylvania. Lost in Translation is now
available in six states, including Massachusetts and its home state of Nevada.
Originally
produced by six-time Jack Herer Cup winning cultivators Tahoe Hydroponics
Company, Lost in Translation has made its name with consumers through its
extensive library of well-known strains with unique flavors and aromas,
including Bubble Bath, WAP and Temptation. Lost in Translation reflects Ayr’s
commitment to high-quality cannabis at scale.
“We’re
proud of the flower we’re growing throughout our footprint and are excited by
the opportunity to delight our customers with a combination of quality flower
and award-winning genetics,” Ayr founder and CEO Jonathan Sandelman said. “The
rollout of a brand for cannabis connoisseurs like Lost in Translation
reiterates Ayr’s commitment to its strategic brand portfolio that meets our
patients and customers wherever they are in their cannabis journey. Flower
remains the predominant method of consumption across the country, so it is
important to have brands that range from value to premium, including Road
Tripper, Kynd and now LIT.”
Lost
in Translation is now available across Ayr’s dispensaries, as well as through
third-party partners in applicable markets.
To
find Lost in Translation near you, visit our dispensary pages for Arizona, Florida, Massachusetts, Nevada, New Jersey, and Pennsylvania. To learn more about Ayr Wellness visit www.ayrwellness.com.
